13F-HR filed by Affinity Asset Advisors, LLC
Affinity Asset Advisors, LLC filed this 13F-HR for the quarter ended 2023-09-30, filed 2023-11-14, with 81 holding rows worth $355,501,523.
- Accession
- 0001999371-23-000200
- Filer
- CIK 1773195
- Filed
- 2023-11-14
- Accepted by EDGAR
- acceptance time not in the bulk data set
- Ingested
- Source
- SEC quarterly data set
13F report for Q3 2023
A holdings report, 81 entries on the cover page, a total value of $355,501,523 stated on the cover page (in dollars after the unit check, H1), rows summing to $355,501,523 with VALUE read as dollars as filed, 13F file number 028-20754. The quarter's positions are built on this report. The resolved quarter.
The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).
| Issuer as filed | CUSIP | Class | Amount | Value | Value read as | Type |
|---|---|---|---|---|---|---|
| APOGEE THERAPEUTICS INC COM | 03770N101 | Stock | 1,045,110 | $22,260,843 | dollars as filed | |
| TEVA PHARMACEUTICAL INDS LTD SPONSORED ADS | 881624209 | ADR | 2,000,000 | $20,400,000 | dollars as filed | |
| CYMABAY THERAPEUTICS INC | 23257D103 | COM | 1,129,376 | $16,838,996 | dollars as filed | |
| BRIDGEBIO PHARMA INC | 10806XAB8 | NOTE 2.500% 3/1 | 17,000,000 | $16,407,550 | dollars as filed | principal |
| CEREVEL THERAPEUTICS HLDNG I | 15678U128 | COM | 685,061 | $14,954,882 | dollars as filed | |
| ARCELLX INC COMMON STOCK | 03940C100 | Stock | 400,000 | $14,352,000 | dollars as filed | |
| CRINETICS PHARMACEUTICALS INC COM | 22663K107 | Stock | 450,000 | $13,383,000 | dollars as filed | |
| MADRIGAL PHARMACEUTICALS INC COM | 558868105 | Stock | 85,000 | $12,413,400 | dollars as filed | |
| ESTABLISHMENT LABS HOLDINGS | G31249108 | COMMON STOCK | 239,108 | $11,733,030 | dollars as filed | |
| IMMUNOVANT INC | 45258J102 | COM | 300,000 | $11,517,000 | dollars as filed | |
| TEVA PHARMACEUTICAL INDS LTD SPONSORED ADS | 881624209 | ADR | 1,100,000 | $11,220,000 | dollars as filed | call |
| XENON PHARMACEUTICALS INC COM | 98420N105 | Stock | 300,438 | $10,262,962 | dollars as filed | |
| KURA ONCOLOGY INC COM | 50127T109 | Stock | 856,535 | $7,811,599 | dollars as filed | |
| ASTRIA THERAPEUTICS INC COM | 04635X102 | Stock | 1,000,300 | $7,462,238 | dollars as filed | |
| ARK ETF TR | 00214Q302 | GENOMIC REV ETF | 250,000 | $6,965,000 | dollars as filed | put |
| ESTABLISHMENT LABS HOLDINGS | G31249108 | COMMON STOCK | 140,000 | $6,869,800 | dollars as filed | call |
| CYTOKINETICS INC | 23282W605 | COM NEW | 230,366 | $6,786,582 | dollars as filed | |
| KRYSTAL BIOTECH INC COM | 501147102 | Stock | 57,500 | $6,670,000 | dollars as filed | |
| CENTESSA PHARMACEUTICALS PLC | 152309100 | SPONSORED ADS | 1,018,091 | $6,587,049 | dollars as filed | |
| MORPHIC HLDG INC | 61775R105 | COM | 270,000 | $6,185,700 | dollars as filed | |
| VERONA PHARMA PLC | 925050106 | SPONSORED ADS | 368,329 | $6,003,763 | dollars as filed | |
| INOZYME PHARMA INC | 45790W108 | COM | 1,379,852 | $5,795,378 | dollars as filed | |
| ALKERMES PLC | G01767105 | SHS | 200,000 | $5,602,000 | dollars as filed | call |
| APELLIS PHARMACEUTICALS INC | 03753U106 | COM | 130,000 | $4,945,200 | dollars as filed | put |
| IMMUNOVANT INC | 45258J102 | COM | 128,100 | $4,917,759 | dollars as filed | put |
| AUTOLUS THERAPEUTICS PLC SPON | 05280R100 | COM | 1,992,466 | $4,642,446 | dollars as filed | |
| SAVARA INC | 805111101 | COM | 1,150,000 | $4,347,000 | dollars as filed | |
| ASCENDIS PHARMA A/S DKK 1.0 AD | 04351P101 | SPONSORED ADR | 46,400 | $4,344,896 | dollars as filed | |
| CELLDEX THERAPEUTICS INC NEW | 15117B202 | COM NEW | 150,000 | $4,128,000 | dollars as filed | |
| ASTRAZENECA PLC SPONSORED ADR | 046353108 | ADR | 60,000 | $4,063,200 | dollars as filed | |
| TANGO THERAPEUTICS INC | 87583X109 | COM | 350,000 | $3,941,000 | dollars as filed | |
| PROTHENA CORP PLC SHS | G72800108 | Stock | 79,214 | $3,822,076 | dollars as filed | |
| VIKING THERAPEUTICS INC | 92686J106 | COM | 332,600 | $3,681,882 | dollars as filed | put |
| Mersana Therapeutics Inc | 59045L106 | Common Stock | 2,850,000 | $3,619,500 | dollars as filed | |
| VIKING THERAPEUTICS INC | 92686J106 | COM | 300,000 | $3,321,000 | dollars as filed | |
| SPYRE THERAPEUTICS INC | 00773J202 | COM NEW | 242,297 | $2,968,138 | dollars as filed | |
| DYNAVAX TECHNOLOGIES CORP | 268158201 | COM NEW | 200,000 | $2,954,000 | dollars as filed | |
| MOONLAKE IMMUNOTHERAPEUTICS CLASS A ORD | 61559X104 | Stock | 50,000 | $2,850,000 | dollars as filed | |
| ALKERMES PLC | G01767105 | SHS | 100,000 | $2,801,000 | dollars as filed | |
| KALVISTA PHARMACEUTICALS INC | 483497103 | COM | 278,292 | $2,679,952 | dollars as filed | |
| MIRATI THERAPEUTICS INC | 60468T105 | COM | 60,426 | $2,632,157 | dollars as filed | |
| IMMATICS N.V | N44445109 | SHS | 200,000 | $2,316,000 | dollars as filed | |
| NUVALENT INC COM | 670703107 | Stock | 50,000 | $2,298,500 | dollars as filed | |
| SEAGEN INC | 81181C104 | COM | 10,000 | $2,121,500 | dollars as filed | |
| LANTHEUS HLDGS INC | 516544103 | COM | 30,000 | $2,084,400 | dollars as filed | |
| NURIX THERAPEUTICS INC | 67080M103 | COMMON STOCK | 250,000 | $1,965,000 | dollars as filed | |
| ACLARIS THERAPEUTICS INC COM | 00461U105 | Stock | 260,000 | $1,781,000 | dollars as filed | put |
| ROIVANT SCIENCES LTD | G76279101 | SHS | 150,000 | $1,752,000 | dollars as filed | |
| TERNS PHARMACEUTICALS INC COM | 880881107 | Stock | 325,000 | $1,634,750 | dollars as filed | |
| APELLIS PHARMACEUTICALS INC | 03753U106 | COM | 40,000 | $1,521,600 | dollars as filed | |
| VAXCYTE INC COM | 92243G108 | Stock | 25,000 | $1,274,500 | dollars as filed | |
| INSPIRE MED SYS INC COM | 457730109 | Stock | 6,293 | $1,248,783 | dollars as filed | |
| EYEPOINT INC COM NEW | 30233G209 | Stock | 155,000 | $1,238,450 | dollars as filed | put |
| NEWAMSTERDAM PHARMA CO NV | N62509109 | COMMON STOCK | 125,000 | $1,156,250 | dollars as filed | |
| MORPHIC HLDG INC | 61775R105 | COM | 50,000 | $1,145,500 | dollars as filed | put |
| TALARIS THERAPEUTICS INC | 87410C104 | COM | 400,000 | $1,124,000 | dollars as filed | |
| THESEUS PHARMACEUTICALS INC | 88369M101 | COM | 400,726 | $1,077,953 | dollars as filed | |
| Milestone Pharmaceuticals Inc | 59935V107 | COM | 335,068 | $1,038,711 | dollars as filed | |
| LIANBIO ADR | 53000N108 | COM | 672,357 | $1,001,812 | dollars as filed | |
| ADC THERAPEUTICS SA | H0036K147 | COMMON STOCK | 1,100,000 | $986,700 | dollars as filed | |
| Inflarx Nv | N44821101 | COM | 325,097 | $968,789 | dollars as filed | |
| SPRINGWORKS THERAPEUTICS INC | 85205L107 | COM | 41,581 | $961,353 | dollars as filed | |
| MIRUM PHARMACEUTICALS INC | 604749101 | COM | 30,000 | $948,000 | dollars as filed | |
| TRAVERE THERAPEUTICS INC | 89422G107 | COM | 100,000 | $894,000 | dollars as filed | |
| INSULET CORP COM | 45784P101 | Stock | 5,000 | $797,450 | dollars as filed | |
| BRIDGEBIO PHARMA INC | 10806X102 | COM | 30,000 | $791,100 | dollars as filed | |
| BIOHAVEN LTD | G1110E107 | COM | 30,156 | $784,358 | dollars as filed | |
| TECTONIC THERAPEUTIC INC COM | 05455M100 | Stock | 500,000 | $770,000 | dollars as filed | |
| IMMATICS N.V | N44445117 | *W EXP 07/01/202 | 187,204 | $662,702 | dollars as filed | |
| 89BIO INC | 282559103 | COM | 37,300 | $575,912 | dollars as filed | call |
| PUMA BIOTECHNOLOGY INC | 74587V107 | COMMON STOCK | 202,349 | $532,178 | dollars as filed | |
| PROMIS NEUROSCIENCES INC | 74346M406 | COM NEW | 265,958 | $526,677 | dollars as filed | |
| CONTEXT THERAPEUTICS INC | 21077P108 | COM | 328,817 | $496,514 | dollars as filed | |
| MESOBLAST LTD F SPONSORED ADR 1 ADR REPS 10 ORD SHS | 590717104 | SPONS ADR | 400,000 | $492,000 | dollars as filed | put |
| NUVATION BIO INC COM CL A | 67080N101 | Stock | 250,000 | $335,000 | dollars as filed | |
| BIOATLA INC | 09077B104 | COM | 180,000 | $306,000 | dollars as filed | |
| ALDEYRA THERAPEUTICS INC | 01438T106 | COM | 44,348 | $296,245 | dollars as filed | |
| NEWAMSTERDAM PHARMA CO NV-27 | N62509117 | WTS | 137,000 | $260,300 | dollars as filed | |
| NLS PHARMACEUTICS LTD COM NEW | H57830103 | Stock | 200,455 | $140,319 | dollars as filed | |
| Aravive Inc | 03890D108 | Common / Ordinary Stock | 346,511 | $45,739 | dollars as filed | |
| Rocket Pharmaceuticals Inc W Exp 09/02/202 | 77313F114 | Warrant | 75,000 | $7,500 | dollars as filed |
Amendment chain
| Filing | Role | Filed | Accepted | Ingested |
|---|---|---|---|---|
| 13F-HR 0001999371-23-000200 | this filing | 2023-11-14 | acceptance time not in the bulk data set |